A Study of CC-95266 in Participants With Relapsed and/or Refractory Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:January 26, 2024Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Multiple MyelomaLast Updated:January 26, 2024Active, not recruiting
Condition(s):Lymphoma, Large B-Cell, DiffuseLast Updated:May 3, 2022Available
Condition(s):Multiple MyelomaLast Updated:March 1, 2023Active, not recruiting
Condition(s):Lymphoma Non-Hodgkin; Agressive Lymphoma; Diffuse-large B-cell Lymphoma (DLBCL)Last Updated:July 6, 2023Active, not recruiting
Condition(s):Lymphoma, Non-Hodgkin; Lymphoma; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Neoplasms; Neoplasms by Histologic Type; Lymphoproliferative Disorders; Lymphatic Diseases; Immunoproliferative Disorders; Immune System DisorderLast Updated:December 6, 2023Completed
Condition(s):Lymphoma, Non-Hodgkin; Lymphoma, Nonhodgkin; Lymphoma, B-Cell; Lymphoma, Large B-Cell, DiffuseLast Updated:December 20, 2023Completed
Condition(s):Non Hodgkin Lymphoma; Multiple Myeloma; Chronic Lymphocytic Leukemia; Diffuse Large B Cell Lymphoma; Mantle Cell Lymphoma; Follicular LymphomaLast Updated:May 4, 2020Terminated
Condition(s):Multiple MyelomaLast Updated:October 23, 2023Completed
Condition(s):Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Small LymphocyticLast Updated:August 29, 2023Active, not recruiting
Condition(s):Acute Lymphoblastic LeukemiaLast Updated:June 3, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.